Respiratory Distress Syndrome of the Newborn
📧 Sign up to get email alerts when something new happens for Respiratory Distress Syndrome of the Newborn.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2015-05-04FDA Approved: CUROSURF — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental labeling application for Curosurf (poractant alfa) from Chiesi USA, Inc., resulting in updated product labeling.